Catherine Scholz is Vice President, Clinical Development after joining Kura in 2015 as Vice President, Development. Dr. Scholz joined Kura with extensive industry experience in drug development, cross-functional global team leadership, project management and collaboration across a variety of therapeutic areas. Prior, she served as Immunology Program Leader at EMD Serono from 2013-2015, where she was accountable for program development strategy and portfolio advancement. From 2008-2013, Dr. Scholz served as Director of Clinical Pharmacology and later as Director/Global Development Team Leader at Millennium Pharmaceuticals. She began her career as Senior Clinical Research Scientist, Clinical Pharmacology at Bayer Schering Pharma. Dr. Scholz received both her Bachelor of Science and Doctor of Pharmacy degrees from Rutgers University.